Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Excessive Daytime Sleepiness in Narcolepsy”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Large-scale testing (Phase 3)Study completedNCT00049803
What this trial is testing

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

Who this might be right for
Narcolepsy
Orphan Medical 200
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Large-scale testing (Phase 3)Study completedNCT01067222
What this trial is testing

Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

Who this might be right for
NarcolepsyExcessive Daytime SleepinessCataplexy+1 more
Bioprojet 110
Large-scale testing (Phase 3)Study completedNCT01638403
What this trial is testing

Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.

Who this might be right for
Treatment of Excessive Daytime Sleepiness in Narcolepsy
Bioprojet 180
Large-scale testing (Phase 3)Study completedNCT00228566
What this trial is testing

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Who this might be right for
Excessive Daytime SleepinessNarcolepsyObstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Cephalon 247
Large-scale testing (Phase 3)Study completedNCT02720744
What this trial is testing

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Who this might be right for
Excessive Daytime SleepinessCataplexyNarcolepsy
Avadel 212
Very early researchWithdrawnNCT03626727
What this trial is testing

Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

Who this might be right for
HypersomniaNarcolepsyTraumatic Brain Injury
Brigham and Women's Hospital
Large-scale testing (Phase 3)Study completedNCT01399606
What this trial is testing

Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)

Who this might be right for
NarcolepsyCataplexy
Bioprojet 102
Testing effectiveness (Phase 2)Study completedNCT01681121
What this trial is testing

The Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

Who this might be right for
Narcolepsy
Jazz Pharmaceuticals 93
Large-scale testing (Phase 3)Study completedNCT00066170
What this trial is testing

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

Who this might be right for
Narcolepsy
Jazz Pharmaceuticals 231
Testing effectiveness (Phase 2)Study completedNCT04923594
What this trial is testing

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

Who this might be right for
NarcolepsyExcessive Daytime SleepinessCataplexy Narcolepsy
NLS Pharmaceutics 67
Testing effectiveness (Phase 2)Study completedNCT01006122
What this trial is testing

A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

Who this might be right for
Excessive Daytime SleepinessNarcolepsy
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT00228553
What this trial is testing

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Who this might be right for
Excessive Daytime SleepinessNarcolepsyObstructive Sleep Apnea/Hypopnea Syndrome+1 more
Cephalon 743
Testing effectiveness (Phase 2)Study completedNCT01485770
What this trial is testing

The Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

Who this might be right for
Narcolepsy
Jazz Pharmaceuticals 33
Large-scale testing (Phase 3)Looking for participantsNCT06767683
What this trial is testing

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Alkermes, Inc. 256
Early research (Phase 1)Study completedNCT05008341
What this trial is testing

Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration

Who this might be right for
NarcolepsyObstructive Sleep ApneaExcessive Daytime Somnolence+2 more
Axsome Therapeutics, Inc. 6
Large-scale testing (Phase 3)Study completedNCT01789398
What this trial is testing

Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)

Who this might be right for
Narcolepsy
Bioprojet 51
Testing effectiveness (Phase 2)Study completedNCT03881852
What this trial is testing

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

Who this might be right for
NarcolepsyCataplexy NarcolepsyExcessive Sleepiness
Axsome Therapeutics, Inc. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06555783
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 80
Large-scale testing (Phase 3)Study completedNCT05113745
What this trial is testing

Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 68
Load More Results